Perfluorohexyloctane Ophthalmic Solution (Miebo) for Dry Eye Disease

The FDA has approved perfluorohexyloctane ophthalmic solution (Miebo – Bausch+Lomb) for treatment of dry eye disease. Available only by prescription, Miebo is the first ophthalmic product to be approved in the US that specifically targets tear evaporation caused by meibomian gland dysfunction. An ophthalmic solution with a similar name, Miebo Tears (Vista), which contains 0.6% propylene glycol, is available over the counter for dry eye relief.